
UNITY Biotechnology Inc
NASDAQ:UBX

Fundamental Analysis


Revenue & Expenses Breakdown
UNITY Biotechnology Inc
Balance Sheet Decomposition
UNITY Biotechnology Inc
Current Assets | 17.6m |
Cash & Short-Term Investments | 16.9m |
Other Current Assets | 714k |
Non-Current Assets | 12.7m |
PP&E | 11.7m |
Other Non-Current Assets | 967k |
Free Cash Flow Analysis
UNITY Biotechnology Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
UNITY Biotechnology Inc
Revenue
|
0
USD
|
Operating Expenses
|
-30.5m
USD
|
Operating Income
|
-30.5m
USD
|
Other Expenses
|
3m
USD
|
Net Income
|
-27.5m
USD
|
UBX Profitability Score
Profitability Due Diligence
UNITY Biotechnology Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Score
UNITY Biotechnology Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
UBX Solvency Score
Solvency Due Diligence
UNITY Biotechnology Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
UNITY Biotechnology Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
UBX Price Targets Summary
UNITY Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
UBX
is 3.315 USD
with a low forecast of 1.01 USD and a high forecast of 6.3 USD.
Dividends
Current shareholder yield for UBX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?